Hsbc Holdings PLC United Therapeutics Corp Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

A detailed history of Hsbc Holdings PLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 225,242 shares of UTHR stock, worth $83.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
225,242
Previous 62,861 258.32%
Holding current value
$83.1 Million
Previous $20 Million 303.09%
% of portfolio
0.05%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$311.04 - $363.55 $50.5 Million - $59 Million
162,381 Added 258.32%
225,242 $80.7 Million
Q2 2024

Aug 12, 2024
SELL
$228.26 - $319.04 $12.3 Million - $17.2 Million
-53,897 Reduced 46.16%
62,861 $20 Million
Q1 2024

May 15, 2024
BUY
$210.76 - $249.51 $4.65 Million - $5.51 Million
22,065 Added 23.3%
116,758 $26.8 Million
Q4 2023

Feb 12, 2024
BUY
$214.88 - $256.94 $1.16 Million - $1.39 Million
5,416 Added 6.07%
94,693 $20.8 Million
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $346,325 - $405,872
1,635 Added 1.87%
89,277 $20.2 Million
Q2 2023

Aug 11, 2023
BUY
$205.19 - $232.99 $4.51 Million - $5.12 Million
21,995 Added 33.5%
87,642 $19.3 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $11.5 Million - $14.9 Million
54,065 Added 466.8%
65,647 $14.7 Million
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $1.13 Million - $1.54 Million
5,507 Added 90.65%
11,582 $3.22 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $61,803 - $74,227
-304 Reduced 4.77%
6,075 $1.27 Million
Q2 2022

Aug 11, 2022
BUY
$174.81 - $241.14 $333,362 - $459,853
1,907 Added 42.64%
6,379 $1.51 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $616,121 - $793,363
-3,708 Reduced 45.33%
4,472 $801,000
Q4 2021

Feb 11, 2022
SELL
$184.32 - $216.08 $11 Million - $12.8 Million
-59,433 Reduced 87.9%
8,180 $1.77 Million
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $10.6 Million - $12.6 Million
58,857 Added 672.19%
67,613 $12.6 Million
Q2 2021

Aug 13, 2021
BUY
$170.47 - $211.93 $1.49 Million - $1.86 Million
8,756 New
8,756 $1.57 Million
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $1.19 Million - $1.35 Million
-7,713 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$101.87 - $151.79 $187,644 - $279,597
-1,842 Reduced 19.28%
7,713 $1.17 Million
Q3 2020

Nov 12, 2020
SELL
$99.9 - $121.13 $43,756 - $53,054
-438 Reduced 4.38%
9,555 $970,000
Q2 2020

Aug 14, 2020
SELL
$92.74 - $125.82 $366,972 - $497,869
-3,957 Reduced 28.37%
9,993 $1.21 Million
Q1 2020

May 15, 2020
SELL
$79.39 - $115.35 $434,025 - $630,618
-5,467 Reduced 28.16%
13,950 $1.32 Million
Q4 2019

Feb 14, 2020
SELL
$78.31 - $95.34 $195,070 - $237,491
-2,491 Reduced 11.37%
19,417 $1.71 Million
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $4.99 Million - $5.73 Million
-66,644 Reduced 75.26%
21,908 $1.75 Million
Q2 2019

Aug 13, 2019
BUY
$76.06 - $120.81 $2.39 Million - $3.8 Million
31,432 Added 55.03%
88,552 $6.91 Million
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $1.49 Million - $1.76 Million
13,873 Added 32.08%
57,120 $6.7 Million
Q4 2018

Feb 13, 2019
SELL
$101.4 - $128.73 $437,642 - $555,598
-4,316 Reduced 9.07%
43,247 $4.71 Million
Q3 2018

Nov 13, 2018
SELL
$113.81 - $129.46 $566,773 - $644,710
-4,980 Reduced 9.48%
47,563 $6.08 Million
Q2 2018

Aug 10, 2018
SELL
$101.14 - $118.31 $442,892 - $518,079
-4,379 Reduced 7.69%
52,543 $5.94 Million
Q1 2018

May 11, 2018
SELL
$107.21 - $151.94 $658,376 - $933,063
-6,141 Reduced 9.74%
56,922 $6.4 Million
Q4 2017

Feb 14, 2018
BUY
$118.58 - $151.28 $1.17 Million - $1.5 Million
9,904 Added 18.63%
63,063 $9.32 Million
Q3 2017

Nov 14, 2017
SELL
$114.6 - $136.81 $2.39 Million - $2.85 Million
-20,825 Reduced 28.15%
53,159 $6.22 Million
Q2 2017

Aug 14, 2017
BUY
N/A
73,984
73,984 $9.6 Million

Others Institutions Holding UTHR

# of Institutions
672
Shares Held
42.4M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email